Gun Jörneskog Selected Research

Glycoproteins (Glycoprotein)

12/2018

Phosphatidylserine expressing microvesicles in relation to microvascular complications in type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gun Jörneskog Research Topics

Disease

11	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 09/2010
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2008
4	Ulcer 01/2012 - 03/2002
3	Inflammation (Inflammations) 10/2021 - 06/2015
3	Autoimmune Diseases (Autoimmune Disease) 10/2021 - 05/2016
3	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 10/2021 - 10/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 02/2012
3	Insulin Resistance 01/2020 - 01/2014
3	Chronic Renal Insufficiency 01/2019 - 01/2015
3	Foot Ulcer 01/2012 - 09/2003
2	Hyperemia 10/2021 - 10/2008
2	Diabetes Complications 01/2020 - 01/2020
2	Vascular Diseases (Vascular Disease) 01/2018 - 01/2007
2	Ischemic Stroke 10/2015 - 01/2014
2	Albuminuria 01/2012 - 01/2008
2	Peripheral Arterial Occlusive Disease 1 08/2011 - 09/2003
2	Diabetic Foot 01/2007 - 03/2002
1	Fatty Liver 10/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2021
1	Body Weight (Weight, Body) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Atherosclerosis 01/2019
1	Ataxia (Dyssynergia) 01/2017
1	Graves Disease (Basedow Disease) 05/2016
1	Transient Ischemic Attack 10/2015
1	Cerebral Small Vessel Diseases 10/2015
1	Carotid Artery Diseases 10/2015
1	Acute Coronary Syndrome 09/2015
1	Glucose Intolerance 01/2014
1	Hyperthyroidism 12/2011
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 08/2011
1	Dyslipidemias (Dyslipidemia) 09/2010
1	Diabetes Mellitus 12/2009
1	Chronic Limb-Threatening Ischemia 07/2008
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2008

Drug/Important Bio-Agent (IBA)

5	FibrinIBA 02/2015 - 09/2010
4	Angiotensin IIIBA 10/2021 - 10/2008
4	Dalteparin (Dalteparin Sodium)FDA Link 01/2012 - 09/2003
3	Insulin (Novolin)FDA Link 10/2021 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2018
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2016 - 07/2014
3	Atorvastatin (Lipitor)FDA Link 11/2013 - 09/2010
2	AngiotensinsIBA 10/2021 - 01/2016
2	HMGB1 Protein (HMG1)IBA 12/2020 - 05/2016
2	P-SelectinIBA 05/2016 - 08/2011
2	Clopidogrel (Plavix)FDA Link 10/2015 - 01/2014
2	Thrombin FDA Link 06/2015 - 08/2011
2	LipidsIBA 11/2013 - 09/2010
2	Endothelin A ReceptorIBA 07/2008 - 01/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	AlarminsIBA 12/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	C-PeptideIBA 01/2020
1	ErythritolIBA 01/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020
1	NucleotidesIBA 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Thiamine MonophosphateIBA 01/2020
1	Interleukin-2 Receptor alpha SubunitIBA 01/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 12/2018
1	PhosphatidylserinesIBA 12/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Phosphates (Orthophosphate)IBA 01/2017
1	E-SelectinIBA 05/2016
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 05/2016
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 05/2016
1	AutoantibodiesIBA 05/2016
1	CD40 Ligand (CD40L)IBA 05/2016
1	C-Reactive ProteinIBA 01/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2016
1	ReninIBA 01/2016
1	Fibrinolysin FDA Link 01/2016
1	paricalcitol (Zemplar)FDA Link 01/2015
1	Plasminogen Activator Inhibitor 1IBA 07/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2012
1	Immunoglobulin G (IgG)IBA 01/2012
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	AlbuminsIBA 01/2012
1	Immunoglobulin M (IgM)IBA 01/2012
1	GlycosaminoglycansIBA 01/2012
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 12/2011
1	Thyroxine (Levothyroxine)FDA LinkGeneric 12/2011
1	Integrin beta3 (GPIIIa)IBA 08/2011
1	Thromboplastin (Tissue Factor)IBA 08/2011
1	AntigensIBA 12/2009
1	von Willebrand FactorIBA 12/2009
1	Metalloproteases (Metalloproteinases)IBA 12/2009

Therapy/Procedure

4	Therapeutics 11/2013 - 03/2002
2	Lasers (Laser) 10/2021 - 10/2008
2	Glycemic Control 01/2021 - 02/2012
2	Intravenous Infusions 06/2015 - 10/2008
2	Subcutaneous Injections 01/2007 - 09/2003
1	Aftercare (After-Treatment) 12/2009